Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

metabolic · Mechanism Report

Does vitamin B6 status determine histamine degradation?

Adequate vitamin B6 (as PLP) is necessary for the enzymatic pathways that neutralize histamine, so B6 status directly affects histamine clearance.

PlausibleJune 19, 20267 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Vitamin B6 status influences histamine degradation because pyridoxal-5'-phosphate is a cofactor used in pathways that help inactivate histamine and related biogenic amines.

laying out figure…
4 of 6 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim states that the active form of vitamin B6, pyridoxal-5'-phosphate (PLP), is a required cofactor for the enzymatic routes that inactivate histamine. Mechanistically, PLP availability modulates PLP-dependent enzymes responsible for oxidative deamination and methylation of histamine, thereby altering the body's capacity to clear histamine and related biogenic amines.

Verified conclusion

The relationship between Vitamin B6 status and histamine degradation is well-established, as the active form of the vitamin, pyridoxal-5'-phosphate (PLP), serves as a critical cofactor for the enzymatic pathways responsible for neutralizing biogenic amines.

Clinical evidence and histamine clearance

Vitamin B6 status directly dictates the body's capacity to clear histamine, particularly through its influence on diamine oxidase (DAO). DAO is the primary enzyme responsible for the extracellular degradation of dietary and endogenous histamine.

  • Histamine Intolerance (HIT): Clinical data indicate that B6 deficiency leads to significantly reduced DAO activity. This impairment prevents the effective clearance of histamine, resulting in histamine intolerance symptoms such as headaches, rhinitis, digestive distress, and eczema.
  • Systemic Impact: Beyond histamine, PLP is essential for the function of dopa decarboxylase (DDC) and various transaminases, which manage the synthesis and deamination of broader biogenic amines.

Mechanistic pathways

The inactivation of histamine occurs via two primary enzymatic routes, both of which are influenced by PLP availability:

  • Diamine Oxidase (DAO): Functioning as a PLP-dependent enzyme, DAO requires B6 to catalyze the oxidative deamination of histamine. Without sufficient PLP, the catalytic capacity of DAO is fundamentally compromised.
  • Histamine N-methyltransferase (HNMT): This intracellular pathway involves the methylation of histamine. PLP is required to stabilize the enzyme-substrate complex and facilitate proper binding, ensuring the conversion of histamine into N-methylhistamine.

Implications for older adults

Biogenic amine regulation is particularly relevant for older populations, such as 74-year-old males, where Vitamin B6 deficiency is common.

  • Deficiency Rates: Research suggests that B6 deficiency may reach up to 50% in the elderly, significantly elevating the risk of impaired histamine catabolism.
  • Clinical Relevance: For these individuals, maintaining optimal PLP levels is essential to support the metabolic clearance of physiologically active nitrogenous compounds and prevent the systemic accumulation of histamine.

Bottom line

Vitamin B6 status is a primary determinant of histamine degradation because its active form, PLP, is an essential cofactor for both DAO and HNMT enzymes. Maintaining adequate B6 levels is crucial for preventing histamine intolerance, particularly in older adults who face a higher risk of deficiency.

References

  1. Copper, biogenic amines, and amine oxidases. — onlinelibrary.wiley.com ↗
  2. Recent advances in the application of microbial diamine oxidases and other histamine-oxidizing enzymes — pmc.ncbi.nlm.nih.gov ↗
  3. Genes of the Histamine Pathway and Common Diseases — link.springer.com ↗
  4. Pathological changes in platelet histamine oxidases in atopic eczema — downloads.hindawi.com ↗
  5. Human Copper-Containing Amine Oxidases in Drug Design and Development — mdpi.com ↗
  6. The Rate of Histamine Degradation by Diamine Oxidase Is Compromised by Other Biogenic Amines — pmc.ncbi.nlm.nih.gov ↗
  7. B-071 Unraveling Histamine Intolerance: Exploring DAO Quantity, Elimination Ratios and Cofactor Influences — academic.oup.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesDoes the MTHFR rs1801131 A1298C variant mildly reduce enzyme activity and have a smaller homocysteine effect than C677T?→Plausible3 sourcesIs TMAO formed from gut microbial conversion of choline and carnitine followed by liver oxidation?→